AMPLIFIED EGFR DRIVES TUMORIGENESIS IN TP53 WILD TYPE GLIOBLASTOMA THROUGH INHIBITION OF p53 FUNCTION BY DNA-PK/p53 BINDING

被引：0

作者：

Ding, Jie ^{[1
]}

Li, Xiaolong ^{[1
]}

Wasylishen, Amanda ^{[1
]}

Gao, Feng ^{[1
]}

Zhao, Yang ^{[1
]}

Baggerly, Keith ^{[1
]}

Lozano, Guillermina ^{[1
]}

Koul, Dimpy ^{[1
]}

Yung, W. K. Alfred ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

NEURO-ONCOLOGY | 2017年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CBIO-02

引用

页码：33 / 33

页数：1

共 50 条

[21] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
MILNER, J
MEDCALF, EA
CELL, 1991, 65 (05) : 765 - 774
[22] p53 pathway dysfunction in AML: beyond TP53 mutations
Post, Sean M.
Kornblau, Steven M.
Quintas-Cardama, Alfonso
ONCOTARGET, 2017, 8 (65) : 108288 - 108289
[23] Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas
Hagel, C
Laking, G
Laas, R
Scheil, S
Jung, R
MildeLangosch, K
Stavrou, DK
EUROPEAN JOURNAL OF CANCER, 1996, 32A (13) : 2242 - 2248
[24] Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function
de Vries, A
Flores, ER
Miranda, B
Hsieh, HM
van Oostrom, CTM
Sage, J
Jacks, T
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) : 2948 - 2953
[25] Germline TP53 Mutations Result into a Constitutive Defect of p53 DNA Binding and Transcriptional Response to DNA Damage
Zerdoumi, Y.
Lanos, R.
Raad, S.
Flaman, J.
Bougeard, G.
Tournier, I.
Frebourg, T.
EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 574 - 575
[26] Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage
Zerdoumi, Yasmine
Lanos, Raphael
Raad, Sabine
Flaman, Jean-Michel
Bougeard, Gaelle
Frebourg, Thierry
Tournier, Isabelle
HUMAN MOLECULAR GENETICS, 2017, 26 (14) : 2591 - 2602
[27] Oligomerization of p53 upon cooperative DNA binding: Towards a structural understanding of p53 function
Chene, P
Jahnke, W
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2002, 41 (10) : 1702 - +
[28] Contribution of the p53 pathway in cancers that carry wild-type p53
Ohki, Rieko
CANCER SCIENCE, 2022, 113 : 1232 - 1232
[29] CHARACTERIZATION OF BACULOVIRUS RECOMBINANT WILD-TYPE P53 - DIMERIZATION OF P53 IS REQUIRED FOR HIGH-AFFINITY DNA-BINDING AND CYSTEINE OXIDATION INHIBITS P53 DNA-BINDING
DELPHIN, C
CAHEN, P
LAWRENCE, JJ
BAUDIER, J
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 223 (02): : 683 - 692
[30] Expression signature of p53 status (p53 signature) for the prediction of TP53 mutation and prognosis in breast cancer.
Ishioka, C.
Takahashi, S.
Ishida, T.
Moriya, T.
Ohuchi, N.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 40S - 40S

← 1 2 3 4 5 →